Abstract
Introduction
The coronavirus disease 2019 (COVID-19) pandemic is a global health concern and has persisted through the emergence of variants that have caused subsequent waves of COVID-19 due to the high dispersion and contagiousness of the virus. The aim of this work was to analyze the epidemiology of the cases of reinfection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants during the third and fourth wave of the COVID-19 pandemic at the Hospital Juárez de México (HJM).Methodology
A prospective study of the cases of SARS-CoV-2 reinfection, variants detected, symptoms, and associated comorbidities was carried out on 1,347 patients who attended the HJM from September 2021 to July 2022.Results
760 (56.4%) and 587 (43.6%) patients were negative and positive for SARS-CoV-2, respectively. The Omicron variant was the most frequent and the most common symptoms were: cough (80%), headache (61.32%), fever (51.6%), and dyspnea (40%). A higher proportion of females were vaccinated, ranging from one dose to the complete schedule. The factors that were associated with a greater risk of death from complications of SARS-CoV-2 reinfection were male gender, diabetes mellitus, and arterial hypertension.Conclusions
Females were the most susceptible to an Omicron reinfection event, even though they were vaccinated. However, the risk of death was higher when the patient was male; being male was a potential risk factor for death from COVID-19 and comorbidities.Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
Front Public Health, 11:1149795, 27 Apr 2023
Cited by: 10 articles | PMID: 37181688 | PMCID: PMC10174068
SARS-CoV-2 immune response and reinfection in vaccinated Maya and mestizo in Southeast of Mexico.
Salud Publica Mex, 66(1, ene-feb):14-16, 08 Dec 2023
Cited by: 1 article | PMID: 38065105
SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023.
BMC Public Health, 24(1):496, 16 Feb 2024
Cited by: 1 article | PMID: 38365671 | PMCID: PMC10870596
SARS-CoV-2 Reinfection and Severity of the Disease: A Systematic Review and Meta-Analysis.
Viruses, 15(4):967, 14 Apr 2023
Cited by: 19 articles | PMID: 37112949 | PMCID: PMC10145185
Review Free full text in Europe PMC